Dutton adds new medicines to Pharmaceutical Benefits Scheme

SUFFERERS of cystic fibrosis and a rare disease that attacks organ function will be able to access cheaper treatments from December.

Health Minister Peter Dutton today announced two new medicines for the diseases would be listed on the Pharmaceutical Benefits Scheme.

The medicines, Kalydeco, for cystic fibrosis and Soliris, or atypical haemolytic uraemic syndrome, will be listed from December 1.

Mr Dutton said listing the Kalydeco medicine would help more than 250 Australians affected by cystic fibrosis, saving about $300,000 a year for each patient.

He also said listing the Soliris medicine, for the ultra-rare aHUS condition, would help sufferers and their families meet the $500,000 annual cost of that medicine.

Listing both medicines on the PBS will cost the government about $238 million over the next four years, the drug manufacturers will have to meet some conditions prior to the listing.
- APN NEWSDESK
 



Breakfast bliss with musical twist at new cafe

premium_icon Breakfast bliss with musical twist at new cafe

'You order what you want and we'll cook it for you,'

Say 'yes' to the dress in new CQ bridal store

premium_icon Say 'yes' to the dress in new CQ bridal store

Boutique offering an exclusive range of budget-friendly designs

Canavan gives Adani protesters a Serena serve

premium_icon Canavan gives Adani protesters a Serena serve

Activists' radical plan to stop CQ's multibillion-dollar coal mines

Local Partners